Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic Multiple Myeloma”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Testing effectiveness (Phase 2)Study completedNCT01572480
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Active Not RecruitingNCT00114101
What this trial is testing

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 460
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Testing effectiveness (Phase 2)Looking for participantsNCT04776395
What this trial is testing

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
Emory University 68
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Testing effectiveness (Phase 2)Ended earlyNCT02943473
What this trial is testing

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Who this might be right for
High Risk Smoldering Multiple Myeloma
Icahn School of Medicine at Mount Sinai 9
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02353572
What this trial is testing

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
University of Colorado, Denver 3
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Not applicableLooking for participantsNCT07446777
What this trial is testing

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
University of Miami 120
Testing effectiveness (Phase 2)Study completedNCT00112827
What this trial is testing

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaSmoldering Multiple MyelomaStage I Multiple Myeloma+2 more
City of Hope Medical Center 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06183489
What this trial is testing

Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
European Myeloma Network B.V. 50
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03815279
What this trial is testing

A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Landspitali University Hospital 80
Not applicableStudy completedNCT05565638
What this trial is testing

PROFAST Intervention in Precursor Multiple Myeloma

Who this might be right for
Cancer PreventionWeight LossSmoldering Waldenstrom Macroglobulinemia(WM)+3 more
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Looking for participantsNCT06140524
What this trial is testing

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 116
Not applicableLooking for participantsNCT06237803
What this trial is testing

European Myeloma Network (EMN) Sample Project

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaPlasma Cell Leukemia+2 more
European Myeloma Network B.V. 6,000
Not applicableWithdrawnNCT03145870
What this trial is testing

Prevalence of Asymptomatic Thrombosis in Multiple Myeloma

Who this might be right for
ThrombosisMultiple Myeloma
Centre Hospitalier Universitaire, Amiens
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960555
What this trial is testing

Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 61
Next Page